Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Mocerino · SciRah

Researcher profile · Semantic Scholar

C. Mocerino

Share profile

C. Mocerino — researcher profile on SciRah

h-index: 10
Works: 29
Citations: 344

Most-cited papers

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
S. De Placido, C. Gallo, M. de Laurentiis, G. Bisagni +223 more
2018The Lancet Oncology77 citations Open access
Semantic Scholar
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
M. Cazzaniga, Graziella Pinotti, E. Montagna, D. Amoroso +67 more
2019Breast49 citations
Semantic Scholar
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study
F. Carlino, A. Diana, A. Ventriglia, A. Piccolo +13 more
2022Cancers37 citations Open access
Semantic Scholar
Somatostatin Analogues according to Ki67 index in neuroendocrine tumours: an observational retrospective-prospective analysis from real life
A. Faggiano, A. Carratù, E. Guadagno, S. Tafuto +12 more
2015OncoTarget36 citations Open access
Semantic Scholar
Pancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment
C. Molino, C. Mocerino, Antonio Braucci, F. Riccardi +5 more
2014World Journal of Surgical Oncology31 citations Open access
Semantic Scholar
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group
A. Faggiano, Silvana Di Maio, C. Mocerino, M. Ottaviano +14 more
2019Endocrine29 citations Open access
Semantic Scholar
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety
F. Riccardi, G. Colantuoni, A. Diana, C. Mocerino +10 more
2018Molecular and clinical oncology15 citations Open access
Semantic Scholar
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
Concetta Sciammarella, A. Luce, F. Riccardi, C. Mocerino +14 more
2020Frontiers in Oncology14 citations Open access
Semantic Scholar
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)
M. Orditura, A. Gravina, F. Riccardi, A. Diana +20 more
2017ESMO Open14 citations Open access
Semantic Scholar
Multidisciplinary approach to breast angiosarcoma in an elderly patient: Repeated local relapses and significant objective responses
C. Mocerino, G. Iannaci, P. Sapere, R. Luise +2 more
2016International Journal of Immunopathology and Pharmacology14 citations Open access
Semantic Scholar
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients
A. Gravina, P. Gargiulo, M. de Laurentiis, L. Arenare +23 more
2025ESMO Open9 citations Open access
Semantic Scholar
Horner’s syndrome: An unusual presentation of metastatic disease in breast cancer
M. Vitale, F. Riccardi, G. Carrillo, M. Trunfio +5 more
2015International Journal of Immunopathology and Pharmacology5 citations Open access
Semantic Scholar
Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report
M. Vitale, F. Riccardi, C. Mocerino, C. Barbato +4 more
2014Journal of Medical Case Reports5 citations Open access
Semantic Scholar
New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III
N. Battelli, C. Mocerino, Michele Montedoro, M. Pistelli +4 more
2025Current Oncology2 citations Open access
Semantic Scholar
Long Progression-free Survival with Afatinib in a Patient with EGFR-unknown Lung Adenocarcinoma after Erlotinib Failure: A Case Report
M. Vitale, S. Scagliarini, F. Riccardi, C. Barbato +4 more
2015Tumori2 citations
Semantic Scholar
Real-world presentation and outcomes of gastroenteropancreatic neuroendocrine neoplasms in Italy: findings from the nationwide Itanet prospective database
F. Panzuto, M. Rinzivillo, S. Partelli, S. Pusceddu +49 more
2026The Lancet Regional Health - Europe1 citations Open access
Semantic Scholar
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study
L. Arecco, M. M. Latocca, E. Blondeaux, F. Riccardi +20 more
2024Breast1 citations Open access
Semantic Scholar
Validation of time to treatment change (TTC) as a surrogate end-point of progression free survival (PFS) for observational trials in metastatic breast cancer patients (MBC): The GIM-13 AMBRA study.
M. Cazzaniga, P. Pronzato, I. Meattini, L. Biganzoli +15 more
20181 citations
Semantic Scholar
Letter: the response to somatostatin analogues in neuroendocrine tumours is influenced by the Ki67 score
A. Faggiano, A. Carratù, Elia Guadagno, S. Tafuto +12 more
2015Alimentary Pharmacology and Therapeutics1 citations Open access
Semantic Scholar
First-Line Chemotherapy with Liposomal Doxorubicin Plus Cyclofosfamide in Metastatic Breast Cancer: A Case Report of Early and Prolonged Response
F. Riccardi, C. Mocerino, C. Barbato, F. Ambrosio +6 more
2013International Journal of Immunopathology and Pharmacology1 citations Open access
Semantic Scholar
The role of sentinel node biopsy (SNB) in elderly breast cancer patients
Raffaella Benevento, A. Santoriello, A. Gambardella, C. Mocerino +3 more
2010BMC Geriatrics1 citations Open access
Semantic Scholar
Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract
A. Pirozzi, F. Riccardi, G. Arpino, C. Mocerino +3 more
2019Medicine0 citations Open access
Semantic Scholar
First-line therapy with fulvestrant (FUL) in HR+ve, HER2-ve advanced pre-treated breast cancer (ABC) patients (pts): Results from the GIM-13 AMBRA Study.
P. Pronzato, G. Mustacchi, M. Giordano, O. Garrone +15 more
20180 citations
Semantic Scholar
Nab-paclitaxel (Nab-P) in patients (pts) with HER2-ve advanced breast cancer (ABC): A focus on the elderly— Preliminary results of the GIM-13 AMBRA study.
G. Mustacchi, P. Pronzato, A. D’Alonzo, C. Mocerino +16 more
20180 citations
Semantic Scholar
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): Final results of the VICTOR-6 study.
M. Cazzaniga, G. Scognamiglio, D. Generali, A. Ferzi +16 more
20180 citations
Semantic Scholar
Synchronous Mammary Metastasis Mimicking a Primary Breast Cancer: A Case Report and Review of Literature
A. Pirozzi, C. Savastano, F. Riccardi, C. Mocerino +3 more
20180 citations Open access
Semantic Scholar
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study.
M. Cazzaniga, L. Orlando, E. Melegari, V. Arcangeli +16 more
2017Annals of Oncology0 citations Open access
Semantic Scholar
18FDG-PET for early prediction of complete response to lapatinib and capecitabine in HER2-positive metastatic breast cancer: a case report.
F. Riccardi, C. Mocerino, C. Barbato, M. Vitale +4 more
2013Tumori0 citations
Semantic Scholar
18FDG-PET for Early Prediction of Complete Response to Lapatinib and Capecitabine in HER2-Positive Metastatic Breast Cancer: A Case Report
F. Riccardi, C. Mocerino, C. Barbato, M. Vitale +4 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Riccardi×18
Invite
F. Riccardi — researcher profile on SciRah
G. Cartenì×10
Invite
G. Cartenì — researcher profile on SciRah
M. Vitale×7
Invite
M. Vitale — researcher profile on SciRah
M. Cazzaniga×6
Invite
M. Cazzaniga — researcher profile on SciRah

×6

Invite

C. Barbato — researcher profile on SciRah

S. De Placido×5

Invite

S. De Placido — researcher profile on SciRah

C. Taverniti×5

Invite

C. Taverniti — researcher profile on SciRah

Invite

A. Faggiano — researcher profile on SciRah

Invite

M. Trunfio — researcher profile on SciRah

Invite

G. Carrillo — researcher profile on SciRah

M. de Laurentiis×4

Invite

M. de Laurentiis — researcher profile on SciRah

Invite

G. Arpino — researcher profile on SciRah